- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $377.36M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $7.35M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $632.97M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $858.76M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.47B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.52B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $937.33M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $911.73M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.21B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.04B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 122.46M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $174.17M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $125.92M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $14.7M |
| Net Income | Q1 2025 · Mar 31, 2024 | $11.35M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $58.06M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $434.45M |